Back to search

Article

Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development

2021-03-14

Abstract excerpt

<h4>ABSTRACT</h4> Pre-existing immune responses towards adenoviral vector limit the use of a vector based on particular serotypes and its clinical applicability for gene therapy and/or vaccination. Therefore, there is a significant interest to vectorize novel adenoviral types that have low seroprevalence in the human population. Here, we describe the discovery and vectorization of a chimeric human adenovirus, whi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f067f390-60e6-5732-92de-78cdc1060007
DOI
10.1101/2021.03.11.435055
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product developmentDOI 10.1101/2021.03.11.435055
Select a neighboring publication to make it the new centre.